Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy

Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy

With the advent of antiretroviral therapy (ART), HIV-infected individuals are now living longer and healthier lives. However, ART does not completely restore health and treated individuals are experiencing increased rates of noncommunicable diseases such as dyslipidemia, insulin resistance, type 2 d...

Full description

Bibliographic Details
Main Authors:	Duale Ahmed, David Roy, Edana Cassol
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2018/6238978

Similar Items

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
by: Rajesh T Gandhi, et al.
Published: (2017-04-01)

A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
by: Anupa Kamat, et al.
Published: (2012-01-01)

Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy.
by: Frederikke F Rönsholt, et al.
Published: (2013-01-01)

Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.
by: Mathilde Ghislain, et al.
Published: (2015-01-01)

Mononuclear phagocyte activation and its role in HIV-1 pathogenesis
by: Cassol, Edana
Published: (2009)

HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress.
by: Andrew Dysangco, et al.
Published: (2017-01-01)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
by: Jana L. Jacobs, et al.
Published: (2019-10-01)

HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
by: Deanna A. Kulpa, et al.
Published: (2015-04-01)

Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults.
by: Emmanuel Maganga, et al.
Published: (2015-01-01)

HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence
by: Frank Maldarelli
Published: (2015-10-01)

Dislipidemia and systemic inflammation in HIV-infected patients against combined antiretroviral therapy.
by: V. A. Vasylenko
Published: (2018-04-01)

A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
by: Daniel B. Reeves, et al.
Published: (2018-11-01)

Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy
by: Genevieve E. Martin, et al.
Published: (2021-06-01)

Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.
by: Cynthia Gay, et al.
Published: (2011-05-01)

Relationship between adherence to antiretroviral therapy and the cost-effectiveness of antiretroviral therapy and the patterns of antiretroviral regimen switches
by: Habib, Mohdhar Jeilan, 1971-
Published: (2008)

Astrocyte Senescence and Metabolic Changes in Response to HIV Antiretroviral Therapy Drugs
by: Justin Cohen, et al.
Published: (2017-08-01)

Persistent intracellular HIV transcription in individuals on stable antiretroviral regimens
by: Dimitrios Pilalas, et al.
Published: (2018-05-01)

Metabolic complications resulting from the use of antiretroviral therapy in HIV-infected patients
by: Abrahams, Zulfa
Published: (2017)

Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
by: C Alvarez, et al.

Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
by: C. Alvarez, et al.
Published: (2010-05-01)

Nutritional and metabolic assessment of HIV patients in use of antiretroviral therapy at Northeastern Brazil
by: Liana Aguiar Braga, et al.
Published: (2010-12-01)

The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia
by: Eugenia Quiros-Roldan, et al.
Published: (2017-12-01)

Interrelationships between HIV, antiretroviral therapy and membrane bound proteins
by: Chandler, Becky
Published: (2003)

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
by: Elizabeth M. Anderson, et al.
Published: (2020-01-01)

ADHERENCE TO ANTIRETROVIRAL THERAPY FOR HIV/AIDS
by: Stela Maris de Mello Padoin, et al.
Published: (2013-09-01)

Antiretroviral therapy of acute HIV-infection
by: A V Kravchenko, et al.
Published: (2004-04-01)

LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy
by: Delphine Planas, et al.
Published: (2021-03-01)

Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy
by: Eunok Lee, et al.
Published: (2019-09-01)

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.
by: Maud Mavigner, et al.
Published: (2009-10-01)

Comprehensive assessment of markers of systemic inflammation and activation of immunity in HIV-positive patients receiving antiretroviral therapy
by: A. Matuzkova, et al.
Published: (2020-12-01)

HIV-Associated Immune Activation and Persistent Inflammation
Published: (2020)

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
by: Timothy J Henrich, et al.
Published: (2017-11-01)

Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
by: Hemalatha Babu, et al.
Published: (2019-08-01)

Associations between HIV Antiretroviral Therapy and the Prevalence and Incidence of Pregnancy in Rakai, Uganda
by: Fredrick. E. Makumbi, et al.
Published: (2011-01-01)

Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report
by: Toro Giuseppe, et al.
Published: (2005-10-01)

Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy
by: Julia Niessl, et al.
Published: (2020-04-01)

Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
by: Rocio Jiménez-Galán, et al.
Published: (2016-07-01)

Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy.
by: Tu-Anh Tran, et al.
Published: (2008-01-01)

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
by: Anna C. Hearps, et al.
Published: (2017-06-01)

Role of drug transporters and metabolic enzymes in antiretroviral drug (ARV) disposition in testicular tissue: potential contribution to HIV-1 persistence
by: R. Bendayan, et al.
Published: (2015-12-01)